Please login to the form below

Not currently logged in
Email:
Password:

Fred Powell joins Celator as chief financial officer

Joins oncology specialist from OraPharma

Fred Powell, Celator Celator has hired Fred Powell as chief financial officer.

He joins from OraPharma, and will be responsible for the oncology specialist's accounting, corporate finance, financial planning, investor relations and administration functions.

"Fred brings a tremendous skill set and experience base to a company at our stage, with a 20-year track record in the biopharmaceutical industry that includes private and public financings, mergers and acquisitions, and domestic and global operations,” said Scott Jackson, CEO of Celator Pharmaceuticals.

“He will make an immediate and substantive contribution to our success."

During his time at OraPharma, Powell helped the company through several transitions, helping to establish it as a stand-alone business after its sale by Johnson & Johnson in late 2010, and then supporting its acquisition by Valeant Pharmaceuticals in June, 2012.

Prior to joining OraPharma, he was the chief financial officer of BMP Sunstone Corporation, a US specialty pharmaceutical, overseeing its eventual sale to Sanofi.

Powell also held senior finance and administration positions at Eximias Pharmaceutical Corporation, Innaphase Corporation, and ERT (formerly EResearch Technology).

20th December 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics